AMYLOID MS
LIVE

Serial Number

88775571

Owner

SHIMADZU CORPORATION

Attorney

LEIGH ANN LINDQUIST

Filing Date

Jan 28, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AMYLOID MS Trademark

Serial Number: 88775571 • Registration: 6297279

AMYLOID MS is a trademark filed by SHIMADZU CORPORATION on January 28, 2020. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SHIMADZU CORPORATION (285 trademarks)

1, NISHINOKYO KUWABARA-CHO
Nakagyo-ku, Kyoto 604-8511 , JP

Entity Type: 03

Trademark Details

Filing Date

January 28, 2020

Registration Date

March 16, 2021

Goods & Services

Chemicals for research purposes, namely, chemicals for use in biochemistry and for use in molecular biology; chemical reagents for research purposes, namely, chemicals for use in biochemistry and for use in molecular biology; diagnostic reagents for scientific use; any of aforesaid goods other than for medical or veterinary purposes

Laboratory research apparatus and instruments for use in blood analysis; Research laboratory measuring and testing machines and instruments for use in blood analysis, namely, mass spectrometer; telecommunication machines and apparatus for use in biochemistry, namely, mass spectrometers sold as a unit with recorded programs for operating mass spectrometers and for receiving, processing, transmitting and displaying data; electronic machines, apparatus and their replacement parts for use in biochemistry, namely, mass spectrometers

Medical diagnostic testing services; medical analysis services for medical treatment and medical diagnostic purposes; medical testing of body fluids in the nature of body fluids analyzing services for clinical examination

Body fluids analyzing services for clinical examination

Medical apparatus and instruments, namely, apparatus for blood analysis, medical diagnostic apparatus for analyzing body fluids and medical diagnostic apparatus for use in principal component analysis in medical biology for analysing body fluids; in vitro diagnostics medical apparatus in the nature of mass spectrometers used in medical facilities

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 16, 2026 REM1
REGISTERED-SUPPLEMENTAL REGISTER
Mar 16, 2021 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 10, 2021 PREV
ASSIGNED TO LIE
Feb 3, 2021 ALIE
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jan 29, 2021 CNTA
EXAMINER'S AMENDMENT ENTERED
Jan 29, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 29, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 29, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 29, 2021 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 6, 2020 GNFN
FINAL REFUSAL E-MAILED
Oct 6, 2020 GNFR
FINAL REFUSAL WRITTEN
Oct 6, 2020 CNFR
DATA MODIFICATION COMPLETED
Sep 21, 2020 DMCC
ASSIGNED TO LIE
Sep 18, 2020 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 10, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 10, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 10, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 10, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2020 CRFA
ASSIGNED TO LIE
Mar 4, 2020 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 28, 2020 PARI
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 28, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2020 NWOS
NEW APPLICATION ENTERED
Jan 31, 2020 NWAP